FlyPharm Limited - Accounts

FlyPharm Limited
Contents Page
For the year ended 31 March 2025

Accountants' report	1
Statement of financial position	2

FlyPharm Limited Accountants' Report For the year ended 31 March 2025
Accountant’s report You consider that the company is exempt from an audit for the year ended 31 March 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. Bush and Company Accountants 31 March 2025 .................................................... Bush and Company Accountants 699b High Road Leyton Leyton E10 6RA E10 6RA 14 August 2025 1

FlyPharm Limited
Accountants' Report
For the year ended 31 March 2025

Accountant’s report
You consider that the company is exempt from an audit for the year ended 31 March 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
Bush and Company Accountants
31 March 2025

....................................................

Bush and Company Accountants
699b High Road Leyton
Leyton
E10 6RA
E10 6RA
14 August 2025

1

FlyPharm Limited
Statement of Financial Position
As at 31 March 2025

	2025		2024
	£	£	£	£
Fixed assets		536,707		47,496
Current assets	2,082,524		1,968,221
Creditors: amount falling due within one year	(1,112,775)		(707,355)
Net current assets		969,749		1,260,866
Total assets less current liabilities		1,506,456		1,308,362
Creditors: amount falling due after more than one year		(200,000)		(200,000)
Accruals and deferred income		(68,171)		(68,171)
Net assets		1,238,285		1,040,191


Capital and reserves		1,238,285		1,040,191

NOTES TO THE ACCOUNTS

General Information

FlyPharm Limited is a private company, limited by shares, registered in England and Wales, registration number 08080553, registration address Bush and Company Accountants, 699 High Road, Leyton, London, E17 6JQ.

The presentation currency is £ sterling.

1.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling which is the functional currency of the company.

2.	Average number of employees Average number of employees during the year was 6 (2024 : 10).

For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.

The financial statements were approved by the director on 14 August 2025 and were signed by:

--------------------------------
Noor Afshan Ahmed Noor Afshan
Director

2


Registered Number: 08080553
England and Wales
Abridged Accounts

for the year ended 31 March 2025
for
FLYPHARM LIMITED